VVOS logo

VIVOS THERAPEUTICS INC

VVOSNASDAQ
🏆 #5026 by market capEarnings Nov 17US Equity
$0.12—
Last available close · quote unavailable
🔔
Track VVOS
Get earnings, price moves & breaking news on Telegram
Track
24h—
7d▼ 6.8%
14d▼ 12.7%
30d▼ 17.2%
ytd▼ 93.9%
1y▼ 95.3%
🏦Market Cap
$4M
Small Cap
📈Revenue Growth (YoY)
45.2%
High Growth
📊Gross Margin
61.9%
High
💵FCF Margin
—
⚖️P/S Ratio
0.2x
Cheap
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
—
52-Week Range
$0.12 – $3.05
Volume (shares)
—
Avg Volume (shares)
—
Shares Outstanding
33.6M
Next Earnings
2026-11-17

Fundamentals Snapshot

Annual Revenue
$17M
Last Q Revenue
$5M
P/E Ratio
—
P/S Ratio
0.2x
EPS (TTM)
$-1.88
Dividend Yield
—
Dilution (1yr)
+57.7%
VVOS logo

VIVOS THERAPEUTICS INC

VVOS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$17M▲ +16.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
60.4%▲ +0.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$20M▲ +78.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$18M▲ +32.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
9.3M▲ +57.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$11M▼ −$16M YoY
StockOtter · stockotter.space

About VIVOS THERAPEUTICS INC

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.